Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2020-08-21 Call Transcript
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Invitation to second quarter and first half results conference call
Call Transcript Classification · 95% confidence The document is an invitation from Vistin Pharma ASA announcing the release of its second quarter and first half 2020 results on August 28, 2020, and inviting interested parties to a conference call with a Q&A session on the same day. This content explicitly describes the setup for discussing earnings results, which aligns perfectly with the definition of a Call Transcript (CT) or, more accurately in this pre-event stage, an announcement leading up to an earnings call. Since the document is an invitation to the conference call where results will be discussed, and it provides dial-in details, it is most closely related to the Call Transcript (CT) category, as it pertains directly to the earnings call event itself, rather than being the Earnings Release (ER) which contains the initial financial highlights, or the Interim Report (IR) which contains the full financials. Given the focus on the conference call logistics, CT is the best fit.
2020-08-21 English
Meldepliktig avslutning av aksjekjøp på termin i Vistin Pharma ASA
Transaction in Own Shares Classification · 95% confidence The document text is very short (727 characters) and describes the finalization of outstanding forward purchase obligations (terminforpliktelser) for a specific number of shares in Vistin Pharma ASA by Intertrade Shipping AS. This action results in a change in the total shareholding percentage (crossing 24.7%). This type of transaction, where a major shareholder completes a pre-arranged purchase or sale of shares, is best classified as a notification of a change in significant share ownership, especially since the transaction itself leads to a new ownership level being reported. While it involves a transaction, the focus is on the resulting ownership change. This aligns most closely with Major Shareholding Notification (MRQ). It is not a Director's Dealing (DIRS) as the entity is a company (Intertrade Shipping AS), not an individual director, although the director's family owns it. It is not a Transaction in Own Shares (POS) as the company is buying shares from a third party, not buying back its own stock. Therefore, MRQ is the most appropriate fit for reporting the resulting ownership level after a transaction.
2020-07-14 Norwegian
Vistin Pharma ASA: Minutes from the extraordinary general meeting
AGM Information Classification · 99% confidence The document text explicitly contains the heading "PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING" and "MINUTES FROM EXTRAORDINARY GENERAL MEETING". This indicates the document is the official record or minutes of a shareholder meeting that was not the regular Annual General Meeting (AGM), but an Extraordinary General Meeting (EGM). Since the provided categories do not have a specific code for EGM Minutes, the closest and most appropriate category is 'AGM Information' (AGM-R), as it covers materials related to general shareholder meetings. The content details the opening, election of the chairman, approval of the agenda, and election of board members, which are standard components of meeting minutes.
2020-06-24 Norwegian
Vistin Pharma ASA: Minutes from the extraordinary general meeting
AGM Information Classification · 99% confidence The document explicitly states it contains the 'Minutes from the extraordinary general meeting' of Vistin Pharma ASA, held on June 24, 2020. This type of document, detailing the proceedings and outcomes of a shareholder meeting, aligns most closely with the 'AGM Information' category, even though it is an EGM (Extraordinary General Meeting) rather than an AGM. The code AGM-R covers general meeting materials. The document is very short (667 chars) and presents the minutes directly, not just announcing their availability, so it is classified as the meeting record itself.
2020-06-24 English
Vistin Pharma ASA: Guide for online participation at EGM
AGM Information Classification · 98% confidence The document is titled 'GUIDE FOR ONLINE PARTICIPATION AT EXTRAORDINARY GENERAL MEETING' and provides step-by-step instructions (using Skype links and interface descriptions) on how shareholders can attend and participate in the EGM digitally. This content directly relates to the logistics and materials surrounding the Annual General Meeting (or Extraordinary General Meeting, which falls under the same category of shareholder meeting materials). Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (2137 chars) is short, but it is the primary material for the meeting participation, not just an announcement that the meeting is happening, making AGM-R a better fit than RPA or RNS.
2020-06-17 English
Vistin Pharma ASA: Guide for online participation at EGM
AGM Information Classification · 90% confidence The document explicitly discusses the 'Guide for online participation at EGM' (Extraordinary General Meeting) for Vistin Pharma ASA. It details how shareholders can participate digitally via Skype, emphasizing that physical presence is not allowed. While it relates to a General Meeting, the core content is a guide/instruction set for participation, not the formal results (DVA) or the primary presentation materials (AGM-R). Since it is a procedural announcement related to a shareholder meeting, and given the limited options, it most closely aligns with the general scope of shareholder/meeting related materials. However, none of the codes perfectly fit 'Guide to EGM Participation'. Given the context of shareholder meetings, AGM-R (AGM Information) is the closest fit, as EGMs often use similar procedural documents as AGMs, although it is not the presentation itself. Given the short length and focus on meeting logistics, it is not the full AGM presentation. I will classify this as AGM-R as it pertains directly to the mechanics of the General Meeting.
2020-06-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.